Compared to the PLC/PRF-5 xenograft group, the tumor growth curve revealed that the tumor growth rate (tumor volume) was significantly increased in PLC/PRF-5LL-37 group (Fig. 6B). This evidence concerns the gene HSPG2 and neoplasm.